This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "eda_edar_nfkb_ectodermal_appendage#EDA-EDAR-EDARADD Canonical NF-kappaB Signaling Failure"). The single best key conformance target is the "EDA-EDAR-EDARADD Canonical NF-kappaB Signaling Failure" node — the tier where EDA, EDAR, EDARADD, and NEMO/IKBKG all converge, matching the GO:0007249 necessary criterion of the Hypohidrotic_Ectodermal_Dysplasias grouping. Conforming nodes substitute the disorder-specific lesion at the ligand (EDA/X-linked HED), receptor (EDAR), adaptor (EDARADD), or IKK-subunit (NEMO/IKBKG) tier. Scope discipline: the deeply pleiotropic NEMO/IKBKG disorder should conform ONLY through its ectodermal-appendage branch node, not as a whole — its innate/adaptive immunodeficiency, incontinentia pigmenti, and osteopetrosis arise from NF-kappaB signaling in other contexts and are out of scope. The transcription-factor ectodermal dysplasias (e.g. TP63) are a mechanistically distinct arm (no EDA ligand, receptor cascade, or NF-kappaB step) and are deliberately NOT conformers of this module despite sharing the clinical class. WNT10A-related HED signals largely upstream through Wnt rather than directly through EDAR-NF-kappaB and is at best a partial/upstream conformer. Modules bind GO and CL terms only and do not use gene bindings; the substituted gene identity is carried on the conforming disorder node.
EDA-EDAR-EDARADD Canonical NF-kappaB Signaling Failure
trigger
The conserved lesion is loss of signaling through the EDA-EDAR-EDARADD receptor complex. EDA, a tumor-necrosis-factor-family ligand, binds the TNF-receptor-family receptor EDAR; ligand binding recruits the EDARADD death-domain adaptor, which links the receptor to the canonical NF-kappaB pathway via the IKK complex (regulatory subunit NEMO/IKBKG). A loss-of-function variant at any tier of this linear cascade — ligand, receptor, adaptor, or IKK subunit — reduces canonical NF-kappaB signal transduction in the developing ectoderm. This is the point at which all EDA-pathway ectodermal dysplasias converge.
Downstream
-
Failed Ectodermal Placode Formation
Show evidence (3 references)
"It comprises three main gene products: EDA, a ligand that belongs to the tumor necrosis factor (TNF)-α family, EDAR, a receptor related to the TNFα receptors, and EDARADD"
Establishes the three-component EDA-EDAR-EDARADD signaling complex whose disruption is the conserved trigger.
"We have analyzed the response of Edar signaling in transfected cells and show that it activates nuclear factor-kappaB (NF-kappaB) in a dose-dependent manner."
Demonstrates that EDAR signaling activates canonical NF-kappaB, the shared downstream readout of the complex. Evidence source is IN_VITRO because this is a transfected-cell signaling assay.
"the ectodysplasin receptor, DL, triggers NF-kappaB through the NEMO protein, indicating that EDA results from impaired NF-kappaB signaling"
Shows that the NEMO/IKBKG IKK subunit is the convergence point of EDAR signaling on NF-kappaB — the ectodermal-dysplasia phenotype of NEMO deficiency results from the same impaired NF-kappaB signaling.
Ectodermal Appendage Morphogenesis Failure
consequence
Failure of placode-dependent appendage morphogenesis produces the characteristic HED triad: aplasia or hypoplasia of eccrine sweat glands (hypohidrosis, with attendant risk of hyperthermia), defective hair follicle development (hypotrichosis), and defective tooth development (hypodontia/anodontia with conical teeth). The organ-specific defects are serially reused outputs of the same upstream signaling failure.
Show evidence (2 references)
"Hypohidrotic ectodermal dysplasia (HED) is a type of genodermatosis characterized by the abnormal development of sweat glands, teeth, and hair."
Establishes the conserved appendage triad — abnormal development of sweat glands, teeth, and hair — as the shared consequence.
"The data provide further evidence that the development of ectodermal appendages is mediated through a tumor necrosis factor/tumor necrosis factor receptor-like signaling pathway"
Confirms that ectodermal-appendage development is mediated by the EDA (TNF/TNF-receptor-like) signaling pathway, tying the appendage failure to the upstream signaling lesion.